Fatemeh Abbasi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatemeh Abbasi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ali Noursina
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publications - Faraz Golafshan
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publications - Farzad Safari
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publications - Hanieh Rouzbahani
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publications - Amir Hossein Ashouri
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 shared publications - Hamid Nasri
Department of Natural Sciences, The University of Georgia, Tbilisi, Georgia
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 48
Cuproptosis in kidney diseases: Mechanisms, pathophysiology, and therapeutic implications
- 11 November 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 48
Open AccessCuproptosis in kidney diseases: Mechanisms, pathophysiology, and therapeutic implications
- Open Access
- 15 October 2026
- Published by Elsevier in Advances in Redox Research
- Vol. 21
Statins as putative modulators of cuproptosis in inflammatory and vascular disease
- 15 October 2026
- Published by Elsevier in Advances in Redox Research
- Vol. 21
Open AccessStatins as putative modulators of cuproptosis in inflammatory and vascular disease
- Open Access
- 14 February 2026
- Published by Probiologists Limited in Journal of Cellular and Molecular Immunology
- Vol. 5 (1) , 5-6
The dichotomous role of A. muciniphila in CRC: from probiotic to postbiotic
We recently engaged with the systematic review by Soheilipour et al.[1], concludes that Akkermansia muciniphila primarily acts as a pathobiont in colorectal cancer (CRC) by exacerbating tumor progression. While the authors provide a comprehensive analysis of the bacterium's pathobiont potential
- 14 February 2026
- Published by Probiologists Limited in Journal of Cellular and Molecular Immunology
- Vol. 5 (1) , 5-6
Open AccessThe dichotomous role of A. muciniphila in CRC: from probiotic to postbiotic
We recently engaged with the systematic review by Soheilipour et al.[1], concludes that Akkermansia muciniphila primarily acts as a pathobiont in colorectal cancer (CRC) by exacerbating tumor progression. While the authors provide a comprehensive analysis of the bacterium's pathobiont potential
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1)
Determination of the Practical Latent Phase for Term and Low-Risk Women with Premature Rupture of Membrane
Background: To compare the outcomes of 12-hour versus 24-hour latent phase durations in low-risk women with premature rupture of membranes (PROM). Materials and Methods: This prospective study included 213 women with PROM at ≥37 weeks of gestation, randomized into two groups: 12-hour ( n = 142) and 24-hour ( n = 71) latent phase management. Participants underwent cervical ripening followed by oxytocin induction. Primary outcomes included cesarean section rates and maternal and neonatal complications. Results: The 24-hour latent phase group showed a clinically relevant but non-significant 32% reduction in cesarean section rates compared to the 12-hour group (OR: 1.32, 95% CI: 0.73-2.38, P = 0.360). No statistically significant differences were observed in maternal complications (emergency cesarean section, atony, chorioamnionitis) or neonatal outcomes (NICU admission, Apgar scores 0.05). Nulliparous women had numerically higher but statistically nonsignificant complication rates than multiparous women (all P values > 0.05). Conclusion: Extending the latent phase to 24 hours in carefully selected PROM cases may offer a clinically meaningful reduction in cesarean sections, though this finding was not statistically significant. The approach did not increase maternal or neonatal risks. Parity-specific trends warrant further investigation.
- 1 October 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1)
Open AccessDetermination of the Practical Latent Phase for Term and Low-Risk Women with Premature Rupture of Membrane
Background: To compare the outcomes of 12-hour versus 24-hour latent phase durations in low-risk women with premature rupture of membranes (PROM). Materials and Methods: This prospective study included 213 women with PROM at ≥37 weeks of gestation, randomized into two groups: 12-hour ( n = 142) and 24-hour ( n = 71) latent phase management. Participants underwent cervical ripening followed by oxytocin induction. Primary outcomes included cesarean section rates and maternal and neonatal complications. Results: The 24-hour latent phase group showed a clinically relevant but non-significant 32% reduction in cesarean section rates compared to the 12-hour group (OR: 1.32, 95% CI: 0.73-2.38, P = 0.360). No statistically significant differences were observed in maternal complications (emergency cesarean section, atony, chorioamnionitis) or neonatal outcomes (NICU admission, Apgar scores 0.05). Nulliparous women had numerically higher but statistically nonsignificant complication rates than multiparous women (all P values > 0.05). Conclusion: Extending the latent phase to 24 hours in carefully selected PROM cases may offer a clinically meaningful reduction in cesarean sections, though this finding was not statistically significant. The approach did not increase maternal or neonatal risks. Parity-specific trends warrant further investigation.
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1) , 37
Correlation Between Delivery Type and Pelvic Floor Dysfunction: A Case-Control Study
Background: Mode of delivery is associated with pelvic floor dysfunction (PFD). Therefore, this study aimed to investigate the relationship between delivery type and PFD six-month after delivery. Materials and Methods: This case-control study included primigravida females who had a normal vaginal delivery with episiotomy (VDE) or uncomplicated cesarean section. All participants underwent an evaluation to check the strength and endurance of the pelvic floor muscles (PFM), intravaginal pressure measurement, electromyographic activity recording of the PFM, and Pelvic Floor Distress Inventory-20 (PFDI-20) questionnaire. Results: In total, 260 patients were enrolled in our study and divided equally into two groups: uncomplicated cesarean delivery and VDE. Our findings showed significant differences in PFM dysfunction, electrical activity, strength, endurance, and vaginal pressure between the two groups. Patients who underwent an uncomplicated cesarean delivery had better outcomes. Conclusion: Our study demonstrated that the severity of PFD in women who underwent uncomplicated cesarean section was lower than that in women who underwent VDE. VDE may cause PFM injury.
- 1 April 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1) , 37
Open AccessCorrelation Between Delivery Type and Pelvic Floor Dysfunction: A Case-Control Study
Background: Mode of delivery is associated with pelvic floor dysfunction (PFD). Therefore, this study aimed to investigate the relationship between delivery type and PFD six-month after delivery. Materials and Methods: This case-control study included primigravida females who had a normal vaginal delivery with episiotomy (VDE) or uncomplicated cesarean section. All participants underwent an evaluation to check the strength and endurance of the pelvic floor muscles (PFM), intravaginal pressure measurement, electromyographic activity recording of the PFM, and Pelvic Floor Distress Inventory-20 (PFDI-20) questionnaire. Results: In total, 260 patients were enrolled in our study and divided equally into two groups: uncomplicated cesarean delivery and VDE. Our findings showed significant differences in PFM dysfunction, electrical activity, strength, endurance, and vaginal pressure between the two groups. Patients who underwent an uncomplicated cesarean delivery had better outcomes. Conclusion: Our study demonstrated that the severity of PFD in women who underwent uncomplicated cesarean section was lower than that in women who underwent VDE. VDE may cause PFM injury.
- Open Access
- 26 March 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-17
Hypoxia signaling in cancer: HIF-1α stimulated by COVID-19 can lead to cancer progression and chemo-resistance in oral squamous cell carcinoma (OSCC)
The potential implications of Coronavirus disease-2019 (COVID-19) on oral squamous cell carcinoma (OSCC) development, chemo-resistance, tumor recurrence, and patient outcomes are explored, emphasizing the urgent need for tailored therapeutic strategies to mitigate these risks. The role of hypoxia-inducible factor 1-alpha (HIF-1α) in OSCC studies has highlighted HIF-1α as a crucial prognostic marker in OSCC, with implications for disease prognosis and patient survival. Its overexpression has been linked to aggressive subtypes in early OSCC stages, indicating its significance as an early biomarker for disease progression. Moreover, dysplastic lesions with heightened HIF-1α expression exhibit a greater propensity for malignant transformation, underscoring its role in early oral carcinogenesis. Cancer patients, including those with OSCC, face an elevated risk of severe COVID-19 complications, which may further impact cancer progression and treatment outcomes. Understanding the interplay between COVID-19 infection, HIF-1α activation, and OSCC pathogenesis is crucial for enhancing clinical management strategies. So, insights from this review shed light on the significance of HIF-1α in OSCC tumorigenesis, metastasis formation, and patient prognosis. The review underscores the need for further research to elucidate the precise mechanisms through which HIF-1α modulates cancer progression and chemo-resistance in the context of COVID-19 infection. Such knowledge is essential for developing targeted therapeutic interventions to improve outcomes for OSCC patients.
- 26 March 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-17
Open AccessHypoxia signaling in cancer: HIF-1α stimulated by COVID-19 can lead to cancer progression and chemo-resistance in oral squamous cell carcinoma (OSCC)
The potential implications of Coronavirus disease-2019 (COVID-19) on oral squamous cell carcinoma (OSCC) development, chemo-resistance, tumor recurrence, and patient outcomes are explored, emphasizing the urgent need for tailored therapeutic strategies to mitigate these risks. The role of hypoxia-inducible factor 1-alpha (HIF-1α) in OSCC studies has highlighted HIF-1α as a crucial prognostic marker in OSCC, with implications for disease prognosis and patient survival. Its overexpression has been linked to aggressive subtypes in early OSCC stages, indicating its significance as an early biomarker for disease progression. Moreover, dysplastic lesions with heightened HIF-1α expression exhibit a greater propensity for malignant transformation, underscoring its role in early oral carcinogenesis. Cancer patients, including those with OSCC, face an elevated risk of severe COVID-19 complications, which may further impact cancer progression and treatment outcomes. Understanding the interplay between COVID-19 infection, HIF-1α activation, and OSCC pathogenesis is crucial for enhancing clinical management strategies. So, insights from this review shed light on the significance of HIF-1α in OSCC tumorigenesis, metastasis formation, and patient prognosis. The review underscores the need for further research to elucidate the precise mechanisms through which HIF-1α modulates cancer progression and chemo-resistance in the context of COVID-19 infection. Such knowledge is essential for developing targeted therapeutic interventions to improve outcomes for OSCC patients.
- Open Access
- 25 May 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 13 (3) , e32279
Hydrochlorothiazide and kidney stone recurrence; an in-depth analysis of the NOSTONE trial
Kidney stones constitute a distressing and often recurring condition with increasing prevalence in the last decades. Despite successful outcomes following kidney stone treatment, the recurrence rate remains notably high. Thiazides have conventionally been the mainstay for preventing kidney stone recurrence, with studies exploring their efficacy at various doses. The NOSTONE study is an exceptional placebo-controlled randomized controlled trial on the effectiveness of different doses of hydrochlorothiazide in preventing kidney stones. Notably commendable for its methodological rigor and comprehensive approach, the study serves as a noteworthy contribution to advancing our understanding of kidney stone prevention strategies. Our study provides a critical evaluation of the NOSTONE study’s investigation into the effectiveness of hydrochlorothiazide in preventing the recurrence of kidney stones, with a primary emphasis on the statistical flaws identified within the NOSTONE study.
- 25 May 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 13 (3) , e32279
Open AccessHydrochlorothiazide and kidney stone recurrence; an in-depth analysis of the NOSTONE trial
Kidney stones constitute a distressing and often recurring condition with increasing prevalence in the last decades. Despite successful outcomes following kidney stone treatment, the recurrence rate remains notably high. Thiazides have conventionally been the mainstay for preventing kidney stone recurrence, with studies exploring their efficacy at various doses. The NOSTONE study is an exceptional placebo-controlled randomized controlled trial on the effectiveness of different doses of hydrochlorothiazide in preventing kidney stones. Notably commendable for its methodological rigor and comprehensive approach, the study serves as a noteworthy contribution to advancing our understanding of kidney stone prevention strategies. Our study provides a critical evaluation of the NOSTONE study’s investigation into the effectiveness of hydrochlorothiazide in preventing the recurrence of kidney stones, with a primary emphasis on the statistical flaws identified within the NOSTONE study.